Browsing by Subject "Wiechers"
Now showing items 1-2 of 2
-
Formulation, in vitro release and transdermal diffusion of pravastatin by the implementation of the delivery gap principle
(2014)Active pharmaceutical ingredients (APIs), which are incorporated in different formulations, i.e. creams, gels, foams, etc., are applied to the skin for a therapeutic effect. This therapeutic effect could either be required ... -
Optimised transdermal delivery of pravastatin
(Elsevier, 2015)Wiechers’ programme “Formulating for Efficacy” initiated a new strategy to optimise the oil phase of topical formulations in order to achieve optimal transdermal drug delivery. This new approach uses the “Delivery Gap ...